Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).

[1]  D. Goff,et al.  Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. , 2007, The American journal of cardiology.

[2]  C. Kendall,et al.  Rosiglitazone (Avandia) and macular edema , 2006, Canadian Medical Association Journal.

[3]  M. Colucciello.  Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. , 2005, Archives of ophthalmology.

[4]  Stephen J. Aldington,et al.  Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. , 2004, Archives of ophthalmology.

[5]  M. C. Leske,et al.  The prevalence of diabetic retinopathy among adults in the United States. , 2004, Archives of ophthalmology.

[6]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[7]  Irene M. Stratton,et al.  UK prospective diabetes study (UKPDS) , 2004, Diabetologia.

[8]  Matthew D. Davis,et al.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.

[9]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[10]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[11]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[12]  F. Ferris,et al.  Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. , 1998, Investigative ophthalmology & visual science.

[13]  F. Ferris,et al.  Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. , 1997, Archives of ophthalmology.

[14]  B. Hoogwerf,et al.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. , 1996, Archives of ophthalmology.

[15]  R. Klein,et al.  The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. , 1995, Journal of diabetes and its complications.

[16]  J. McGill,et al.  Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus. , 1994, Archives of internal medicine.

[17]  R. Klein,et al.  Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. , 1994, Archives of internal medicine.

[18]  H. Chase,et al.  Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. , 1993, Ophthalmology.

[19]  M. Pfeifer,et al.  Risk of Early-Onset Proliferative Retinopathy in IDDM Is Closely Related to Cardiovascular Autonomic Neuropathy , 1992, Diabetes.

[20]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. , 1991, Ophthalmology.

[21]  R. Klein,et al.  The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. , 1991, American journal of epidemiology.

[22]  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[23]  L. Rand,et al.  Risk Factors for Progression of Background Retinopathy in Long-Standing IDDM , 1989, Diabetes.

[24]  P. Wilson,et al.  Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure , 1988, Diabetes Care.

[25]  L. Rand,et al.  Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up Study , 1986, Diabetes Care.